Resources for Trials Impacted by COVID-19

Complimentary Scientific Consultation

The COVID-19 pandemic and associated social distancing measures are creating unprecedented challenges for everyone working in clinical trials and drug development. VeraSci is here to help. Contact us today for a complimentary consultation with our scientific and regulatory experts.

Remote Assessments for Clinical Trials During the COVID-19 Pandemic

With many subjects isolating themselves at home and many sites concerned about seeing subjects in-person for routine study visits, on-going clinical trials will need to make difficult decisions about whether to skip scheduled visits, try to conduct visits remotely, or in some instances, delay or cancel the trial. Learn more about how VeraSci is responding to these challenges.

Remote Motor Assessments

Many CNS clinical trials include motor assessments as either an outcome measure, like in many Parkinson’s disease trials, or to detect motor side effects like tardive dyskinesia. Learn more about conducting remote motor assessments.

Remote Cognitive Assessments

Cognitive assessments present unique challenges when it comes to remote administration. Learn more about remote administration of cognitive assessments.

Understanding the Difference between Centralized Review, Centralized Scoring, and Remote Assessment

As we’ve been having conversations with sponsors about their options, we’ve noticed some confusion in three related but different terms—centralized review, centralized scoring, and remote assessment. Learn the difference between these terms.

Communication is Critical

As we coordinate new ways to continue working safely, clear communication is a bigger priority than ever before. Efficient, high-quality translations and cultural adaptation are crucial to the creation of remote solutions for international clinical trials.